• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Selective Pelvic Lymph Node Dissection Increases Operative Burden With Uncertain Recurrence Benefit

by
November 18, 2026
in Health
Reading Time: 3 mins read
0
Selective Pelvic Lymph Node Dissection Increases Operative Burden With Uncertain Recurrence Benefit

Selective Pelvic Lymph Node Dissection Increases Operative Burden With Uncertain Recurrence Benefit

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A systematic review and meta-analysis evaluating rectal adenocarcinoma treatments has found that performing selective lateral pelvic lymph node dissection following neoadjuvant therapy increases surgical duration and hospital stays without demonstrating a clear reduction in local cancer recurrence. Analyzing comparative clinical studies of patients with clinically suspicious lateral pelvic nodes, researchers reported that the statistical effect of surgical dissection on lateral or local pelvic recurrence remained highly uncertain, with pooled estimates displaying a wide confidence range that encompassed both notable benefit and increased risk.

Managing clinically suspicious lateral pelvic lymph nodes following neoadjuvant therapy remains one of the most actively debated issues in contemporary rectal cancer surgery. Proponents indicate that selective lateral pelvic lymph node dissection, often abbreviated as LPLND, may improve compartment-specific disease control for patients presenting with persistent or high-risk lateral nodal disease. However, routine or selective application of the procedure continues to be controversial due to significant concerns surrounding increased operative burden, treatment selection bias, and uncertain oncologic benefit in the era of modern magnetic resonance imaging-guided neoadjuvant strategies.

To evaluate the clinical value of this surgical intervention, investigators conducted a systematic review and meta-analysis comparing lateral pelvic lymph node dissection against omission across major biomedical databases. A comprehensive literature search of PubMed and MEDLINE, Scopus, and Web of Science yielded 1,021 records. Following systematic deduplication and screening against predefined criteria, the research team identified three eligible comparative studies evaluating post-neoadjuvant outcomes in rectal adenocarcinoma patients with clinically suspicious lateral pelvic nodes, pooling available outcome data using random-effects meta-analyses.

The methodological framework incorporated formal evaluation of study quality and evidence certainty across the included investigations. Researchers evaluated the risk of bias in the included comparative studies using the ROBINS-I assessment tool, while the overall certainty of evidence was appraised using the GRADE framework.

Across the three eligible comparative studies, the meta-analysis synthesized data from a total cohort of 301 patients, comprising 139 patients in the dissection group and 162 patients in the non-dissection group. When evaluating the primary oncologic outcome of lateral or local pelvic recurrence, dissection yielded a pooled risk ratio of 0.66 with a 95 percent confidence interval spanning from 0.12 to 3.59. This wide confidence interval encompassed both a substantial reduction and a substantial increase in recurrence risk, rendering the effect highly uncertain.

Secondary oncologic and pathologic endpoints evaluated across the pooled cohorts similarly demonstrated no statistically significant differences between the two treatment strategies. The pooled risk ratio for pathologic nodal positivity was 1.24 with a 95 percent confidence interval of 0.92 to 1.68, while the risk ratio for advanced residual tumor stage was 0.95 with a 95 percent confidence interval of 0.79 to 1.13. Distant or systemic recurrence rates were likewise comparable between groups, exhibiting a pooled risk ratio of 1.06 with a 95 percent confidence interval of 0.62 to 1.83.

While oncologic advantages remained undetectable across pooled comparisons, surgical morbidity metrics confirmed a significantly increased operative burden associated with lateral pelvic lymph node dissection. Operative time was significantly longer in the dissection group, showing a mean difference of 87.27 minutes with a 95 percent confidence interval of 47.98 to 126.56 minutes. Length of hospital stay was also significantly extended by a mean difference of 1.00 day, with a 95 percent confidence interval of 0.30 to 1.71 days, whereas estimated blood loss differences were not statistically significant at a mean difference of 119.18 milliliters.

Long-term survival endpoints could not be quantitatively evaluated because comparable time-to-event estimates for disease-free survival and overall survival were unavailable across the included publications. In addition, the leave-one-out sensitivity analysis did not resolve the substantial imprecision observed in the primary recurrence outcome. The review team concluded that their findings represent an objective state-of-the-evidence summary indicating that selective dissection increases surgical burden without offering statistically detectable oncologic benefits, meaning the available data do not support definitive practice-changing recommendations.

Subject of Research: Lateral pelvic lymph node dissection versus omission in rectal adenocarcinoma

Article Title: Selective lateral pelvic lymph node dissection versus omission after neoadjuvant therapy for rectal adenocarcinoma with clinically suspicious lateral pelvic nodes: a systematic review and meta-analysis

Article References: Ullah, S. E., Mirza, W., Nand, R., Javed, M. A., Ali, Z., Khan, H. M., Riaz, J., & Al-Emam, A. (2026). Selective lateral pelvic lymph node dissection versus omission after neoadjuvant therapy for rectal adenocarcinoma with clinically suspicious lateral pelvic nodes: a systematic review and meta-analysis. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-026-05267-8

Image Credits: AI Generated

DOI: 10.1007/s00384-026-05267-8

Keywords: rectal adenocarcinoma, lateral pelvic lymph node dissection, neoadjuvant therapy, pelvic recurrence, operative time, hospital stay, estimated blood loss, systematic review, meta-analysis, ROBINS-I, GRADE certainty, pathologic nodal positivity, residual tumor stage, systemic recurrence, disease-free survival, overall survival, MRI-guided therapy, leave-one-out sensitivity analysis

News Source: Ophelia Keating. (November 18, 2026). Selective Pelvic Lymph Node Dissection Increases Operative Burden With Uncertain Recurrence Benefit. Scienmag.

Tags: disease-free survivalestimated blood lossGRADE certaintyhospital staylateral pelvic lymph node dissectionLeave-One-Out Sensitivity AnalysisMeta-analysisMRI-guided therapyneoadjuvant therapyoperative timeoverall survivalpathologic nodal positivitypelvic recurrencerectal adenocarcinomaresidual tumor stageROBINS-Isystematic reviewsystemic recurrence
Share12Tweet7Share2ShareShareShare1

Related Posts

Persistent Intracellular Microbes Beyond The Gut Regulate Human Tissue Setpoints

Persistent Intracellular Microbes Beyond The Gut Regulate Human Tissue Setpoints

November 18, 2026
Qualitative Study Maps Core Educational Needs in Nursing Ethics Training

Qualitative Study Maps Core Educational Needs in Nursing Ethics Training

November 18, 2026

Study Details Major Shifts in Poland’s Carbapenem-Resistant Bacteria Across Successive Crises

November 18, 2026

Inpatient Bipolar Mania Patients Report Mixed Experiences With Behavioral Management

November 18, 2026

POPULAR NEWS

  • Nurse-Led Interventions Ease Cancer Distress but Personalization Trials Are Needed

    Nurse-Led Interventions Ease Cancer Distress but Personalization Trials Are Needed

    29 shares
    Share 12 Tweet 7
  • Analysis of 1.2 Million Patients Finds 7.6 Percent Surgical Complication Rate

    29 shares
    Share 12 Tweet 7
  • Alcohol Weakens Anti-PD-1 Cancer Immunotherapy in Mice, Study Finds

    29 shares
    Share 12 Tweet 7
  • Presurgical Axitinib and Immunotherapy Linked to Shorter Kidney Cancer Thrombus Surgery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Persistent Intracellular Microbes Beyond The Gut Regulate Human Tissue Setpoints

Qualitative Study Maps Core Educational Needs in Nursing Ethics Training

Review Evaluates Biomarker Readiness for Triage Following Positive High-Risk HPV Screening

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.